Welcome

Welcome to the POZ/AIDSmeds Community Forums, a round-the-clock discussion area for people with HIV/AIDS, their friends/family/caregivers, and
others concerned about HIV/AIDS. Click on the links below to browse our various forums; scroll down for a glance at the most recent posts; or join in the
conversation yourself by registering on the left side of this page.

Privacy Warning: Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If you are HIV positive
and disclose this in our forums, then it is almost the same thing as telling the whole world (or at least the World Wide Web). If this concerns you, then do not use a
username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.

The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own
physician.

All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.

Forums members must behave at all times with respect and honesty. Posting guidelines, including time-out and banning policies, have been established by the moderators
of these forums. Click here for “Am I Infected?” posting guidelines. Click here for posting guidelines pertaining to all other POZ/AIDSmeds community forums.

We ask all forums members to provide references for health/medical/scientific information they provide, when it is not a personal experience being discussed. Please
provide hyperlinks with full URLs or full citations of published works not available via the Internet. Additionally, all forums members must post information which are
true and correct to their knowledge.

A team of researchers from the Universite de Montreal and the Centre hospitalier de l'Universite de Montreal (CHUM) have announced an important breakthrough in fighting the human immunodeficiency virus (HIV). For the first time, scientists have identified a defect in the immune response to HIV and found a way to correct the flaw. Dr. Rafick-Pierre Sekaly, an eminent researcher in cell biology, immunology, and virology, has confirmed the identification of a new therapeutic target (the PD-1 protein) that restores the function of the T cells whose role is to eliminate cells infected with the virus. This constitutes a major breakthrough, opening new prospects for the development of therapeutic strategies for controlling HIV infection. The research findings appear in today's issue of the journal Nature Medicine.

Dr. Sekaly explained that "immune system cells made non-functional by HIV can be identified by the presence of a protein that is significantly overexpressed when infected by the virus." In fact, high levels of the protein are associated with a more serious dysfunction. "The most important discovery made in this study arises from the fact that by stimulating this protein, we succeeded in preventing the virus from making immune system cells dysfunctional," he added.

The findings were simultaneously reproduced by two other laboratories - the labs headed by Dr. Bruce Walker at Harvard and Dr. Richard Koup at the NIH.

"It's a rare occurrence for three teams to work together on attacking a major problem. Up until now, the virus has been more or less invincible. By combining our efforts, we found the missing link that may enable us to defeat the virus," noted Dr. Sekaly. Discussions with partners are also underway to translate these research findings into clinical trials, which could start during the coming year.

Thanks to the joint efforts of the Universite de Montreal, the CHUM Research Centre, Genome Quebec, Genome Canada, the Canadian Institutes of Health Research (CIHR), the Canada Foundation for Innovation, the NIH, and the Fonds de la recherche en sante du Quebec (FRSQ), Quebec continues to show great leadership in the life sciences.

Paul L'Archeveque and Martin Godbout, the presidents of Genome Quebec and Genome Canada respectively, saluted the vision of the research team and the importance for Quebec and Canada of continuing to invest in genomics research. "The $14 million invested in this project certainly played a role in accelerating the researchers' work, and in helping Montreal to remain competitive on the international scene," noted the agency heads, adding that Dr. Sekaly's team was the first in the world to present the findings of this major study.

"The results of Dr. Sekaly's study represent an important step in the development of a new therapeutic approach in the fight against HIV," said Dr. Alan Bernstein, CIHR President. "This study is a compelling example of the excellence of Canadian health researchers and of Canada's contribution to the world's response to the HIV-AIDS pandemic."

"This important discovery is a powerful example of what can be achieved through partnership," added Dr. Eliot Phillipson, President and CEO of the Canada Foundation for Innovation. "Canada is proud to have researchers of Dr. Sekaly's calibre keeping our country at the forefront of the global fight against HIV-AIDS."

Dr. Mark Wainberg, Co-Director of the FRSQ-AIDS and infectious diseases Network and Co-Chair of the 16th World AIDS Conference held in Toronto last week, congratulated Dr. Sekaly and his team: "This scientific breakthrough is a giant step in the fight against AIDS. It is particularly interesting to see that some of the best research teams are working together to stop this terrible curse."

I firmly believe we must look outside the USA for breakthroughs in science, as well as pressuring the US to utilize stem cell and genetic research.

Logged

"Many people, especially in the gay community, turn to oral sex as a safer alternative in the age of AIDS. And with HIV rates rising, people need to remember that oral sex is safer sex. It's a reasonable alternative."

Awesome news indeed. I read this on the Wall Street Journal, and it went into quite a bit into the technical detail. I can't remember exactly, but I think it had to do with the P1 molecule on the outside of the CD8 cells that interacted with another molecule of the virus. The results was that the CD8 cell was incapacitaded and could not seek and kill other infected cells. The best part was that they were able to use some kind of antibody to interrupt this interaction in lab tests, thereby reactivating the CD8 cell to work properly. This raises the exciting possibility that this could lead to a way to make the body fight off the infection on its own, maybe to the point of completely eliminating the infection...!

Logged

"Hope is my philosophy Just needs days in which to beLove of Life means hope for meBorn on a New Day" - John David